Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
Clinical trial NCT07480733 · RECRUITING
Trial details
- NCT number
- NCT07480733
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-23
- Primary completion
- 2027-11-30
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.